Background: Chromosome 22q11 deletion syndrome (22q11DS) increases the risk of development of schizophrenia more than 10 times compared with that of the general population, indicating that haploinsufficiency of a subset of the more than 20 genes contained in the 22q11DS region could increase the risk of schizophrenia. In the present study, we screened for genes located in the 22q11DS region that are expressed at lower levels in postmortem prefrontal cortex of patients with schizophrenia than in those of controls.
Methods: Gene expression was screened by Illumina Human-6 Expression BeadChip arrays and confirmed by real-time reverse transcription-polymerase chain reaction assays and Western blot analysis.
Results: Expression of GNB1L was lower in patients with schizophrenia than in control subjects in both Australian (10 schizophrenia cases and 10 controls) and Japanese (43 schizophrenia cases and 11 controls) brain samples. TBX1 could not be evaluated due to its low expression levels. Expression levels of the other genes were not significantly lower in patients with schizophrenia than in control subjects. Association analysis of tag single-nucleotide polymorphisms in the GNB1L gene region did not confirm excess homozygosity in 1918 Japanese schizophrenia cases and 1909 Japanese controls. Haloperidol treatment for 50 weeks increased Gnb1l gene expression in prefrontal cortex of mice.
Conclusions: Taken together with the impaired prepulse inhibition observed in heterozygous Gnb1l knockout mice reported by the previous study, the present findings support assertions that GNB1L is one of the genes in the 22q11DS region responsible for increasing the risk of schizophrenia.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894596 | PMC |
| http://dx.doi.org/10.1093/schbul/sbn160 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phenotype of patients with late diagnosis of 22q11 deletion: a review and retrospective study.
Intern Med J
December 2024
Immunology Laboratory, Monash Health, Melbourne, Victoria, Australia.
Article Synopsis
- Chromosome 22q11.2 deletion syndrome (22q11DS) is a common genetic condition often identified in infants, but many cases are diagnosed later in life, especially during adolescence and adulthood.
- A study analyzed patients diagnosed after age 13 from 2010-2021 in Melbourne, revealing key clinical features like intellectual disability, hypocalcaemia, and facial dysmorphism in late-diagnosed individuals, while traditional signs like cardiac defects may be absent in adults.
- The findings emphasize the condition's complex and varied symptoms, highlighting the need for awareness of atypical presentations to reduce underdiagnosis.
Genetic overlap between idiopathic scoliosis and schizophrenia in the general population.
Spine Deform
October 2024
Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Article Synopsis
- - The study investigates the genetic relationship between Adolescent Idiopathic Scoliosis (AIS) and Schizophrenia (SCZ), particularly focusing on the 22q11.2 deletion syndrome, which greatly increases the risk for both conditions in adolescents.
- - Researchers utilized data from three genome-wide association studies (GWAS) to analyze single nucleotide polymorphisms (SNPs) linked to both AIS and SCZ, while also examining gene networks related to the 22q11.2 region.
- - Findings showed a significant genetic overlap between AIS and SCZ, with the most impactful SNPs forming a meaningful enrichment cluster, indicating a potential shared biological pathway.
Resolving the 22q11.2 deletion using CTLR-Seq reveals chromosomal rearrangement mechanisms and individual variance in breakpoints.
Proc Natl Acad Sci U S A
July 2024
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305.
Article Synopsis
- The researchers developed a new method called CRISPR/Cas9-targeted long-read sequencing (CTLR-Seq) to analyze complex regions of the human genome that traditional sequencing couldn't handle, especially large segmental duplications (SegDups) and their related rearrangements.
- CTLR-Seq uses a combination of Cas9 cutting and specialized gel techniques to isolate large genomic regions, enabling high-quality long-read sequencing for complete assembly of these previously elusive sequences.
- This method was applied to the 22q11.2 Deletion Syndrome, allowing the team to map out significant genomic rearrangements with high variability linked to transposons and discover cell-type-specific interactions and DNA methylation patterns in patient-derived cells.
Computer-vision analysis of craniofacial dysmorphology in 22q11.2 deletion syndrome and psychosis spectrum disorders.
J Neurodev Disord
June 2024
Brain Behavior Laboratory, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Background: Minor physical anomalies (MPAs) are congenital morphological abnormalities linked to disruptions of fetal development. MPAs are common in 22q11.2 deletion syndrome (22q11DS) and psychosis spectrum disorders (PS) and likely represent a disruption of early embryologic development that may help identify overlapping mechanisms linked to psychosis in these disorders.
View Article and Find Full Text PDFNext-generation sequencing profiling of miRNAs in individuals with 22q11.2 deletion syndrome revealed altered expression of miR-185-5p.
Hum Genomics
June 2024
Genetics Division, Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, Brazil.
Background: The 22q11.2 deletion syndrome (22q11.2DS) is a microdeletion syndrome with highly variable phenotypic manifestations, even though most patients present the typical 3 Mb microdeletion, usually affecting the same ~ 106 genes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!